Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Decker

Showing results (271-280 of 296) with videos related to

Pageof 30
Sort By:
Journal of Thoracic Disease|July 11, 2022
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 4: systematic review of evidence involving SBRT and ablationHenry S Park, Frank C Detterbeck, David C Madoff, et al.
JAMA Oncology|February 21, 2020
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled TrialSalma K Jabbour, Abigail T Berman, Roy H Decker, et al.
Clinical Lung Cancer|April 15, 2018
Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of ImmunotherapyNavika D Shukla, Ameen A Salahudeen, Gregory A Taylor, et al.
Journal of Thoracic Disease|July 11, 2022
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 1: a guide to decision-makingFrank C Detterbeck, Justin D Blasberg, Gavitt A Woodard, et al.
Journal of Thoracic Disease|July 11, 2022
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 3: systematic review of evidence regarding surgery in compromised patients or specific tumorsBrett C Bade, Justin D Blasberg, Vincent J Mase, et al.
Cell Reports. Medicine|January 19, 2024
Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potentialAnouk M D Becker, Annika H Decker, Georgina Flórez-Grau, et al.
Scientific Reports|September 21, 2018
Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural NetworksBenjamin H Kann, Sanjay Aneja, Gokoulakrichenane V Loganadane, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2021
Rates of invasive disease and outcomes in NSCLC patients with biopsy suggestive of carcinoma in situWesley J Talcott, Joseph A Miccio, Henry S Park, et al.
American Journal of Clinical Oncology|March 21, 2013
ACR Appropriateness Criteria® radiation therapy for small-cell lung cancerFeng-Ming Kong, Brian E Lally, Joe Yujiao Chang, et al.
Journal of the American College of Radiology : JACR|July 30, 2013
ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intentKenneth E Rosenzweig, Joe Yujiao Chang, Indrin J Chetty, et al.
Pageof 30

Showing results (271-280 of 296) with videos related to

Sort By:
Pageof 30
Journal of Thoracic Disease|July 11, 2022
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 4: systematic review of evidence involving SBRT and ablationHenry S Park, Frank C Detterbeck, David C Madoff, et al.
JAMA Oncology|February 21, 2020
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled TrialSalma K Jabbour, Abigail T Berman, Roy H Decker, et al.
Clinical Lung Cancer|April 15, 2018
Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of ImmunotherapyNavika D Shukla, Ameen A Salahudeen, Gregory A Taylor, et al.
Journal of Thoracic Disease|July 11, 2022
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 1: a guide to decision-makingFrank C Detterbeck, Justin D Blasberg, Gavitt A Woodard, et al.
Journal of Thoracic Disease|July 11, 2022
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 3: systematic review of evidence regarding surgery in compromised patients or specific tumorsBrett C Bade, Justin D Blasberg, Vincent J Mase, et al.
Cell Reports. Medicine|January 19, 2024
Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potentialAnouk M D Becker, Annika H Decker, Georgina Flórez-Grau, et al.
Scientific Reports|September 21, 2018
Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural NetworksBenjamin H Kann, Sanjay Aneja, Gokoulakrichenane V Loganadane, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2021
Rates of invasive disease and outcomes in NSCLC patients with biopsy suggestive of carcinoma in situWesley J Talcott, Joseph A Miccio, Henry S Park, et al.
American Journal of Clinical Oncology|March 21, 2013
ACR Appropriateness Criteria® radiation therapy for small-cell lung cancerFeng-Ming Kong, Brian E Lally, Joe Yujiao Chang, et al.
Journal of the American College of Radiology : JACR|July 30, 2013
ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intentKenneth E Rosenzweig, Joe Yujiao Chang, Indrin J Chetty, et al.
Pageof 30